High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.
Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MS, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS.
Desai K, et al. Among authors: srinath bs.
Cancer Med. 2016 Aug;5(8):2000-11. doi: 10.1002/cam4.756. Epub 2016 May 17.
Cancer Med. 2016.
PMID: 27184932
Free PMC article.